Literature DB >> 2529880

Myocardial collagen and mechanics after preventing hypertrophy in hypertensive rats.

S Narayan1, J S Janicki, S G Shroff, R Pick, K T Weber.   

Abstract

To determine if a remodeling of the collagen matrix would occur in the absence of hypertrophy and cell necrosis and if such a remodeling could alter active and passive stiffness of the intact myocardium, five rats with genetic hypertension (SHR) were treated (SHRT) with hydralazine for 32 weeks, beginning at four weeks of age, and compared to six age- and sex-matched SHR and seven Wistar-Kyoto genetic control rats (WKY). Left ventricular (LV) weight of SHRT was 17% lower (P less than .001) than that of SHR and 19% higher (P less than .01) than that of WKY. Collagen volume fraction of SHR (13.7 +/- 3.2%) and SHRT (9.9 +/- 1.8%) were greater (P less than .01) than WKY (5.0 +/- 1.9%). Diastolic and systolic stress-strain relations were determined in the isolated heart. A comparison of these relations revealed: 1) a 24% increase in passive stiffness for SHR and SHRT; and 2) a reduced zero-strain intercept (41% to 54%) and slope (36% to 48%) of the developed stress-strain relation for the SHRT. Thus, in SHR, collagen remodeling occurred in the absence of hypertrophy which suggests that the muscular and collagenous compartments of the myocardium are under separate controls. The excess accumulation of collagen in SHR and SHRT leads to abnormal passive stiffness, and the prevention of hypertrophy with hydralazine reduces active stiffness.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529880     DOI: 10.1093/ajh/2.9.675

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Disruption of the myocardial extracellular matrix leads to cardiac dysfunction.

Authors:  H E Kim; S S Dalal; E Young; M J Legato; M L Weisfeldt; J D'Armiento
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  The effect of non-antihypertensive doses of angiotensin converting enzyme inhibitor on myocardial necrosis and hypertrophy in young rats with renovascular hypertension.

Authors:  B B Matsubara; L S Matsubara; M Franco; J C Padovani; J S Janicki
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

Review 3.  Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression.

Authors:  M Eghbali; K T Weber
Journal:  Mol Cell Biochem       Date:  1990-07-17       Impact factor: 3.396

4.  Left ventricular stiffness in paediatric patients with end-stage kidney disease.

Authors:  Ann Wing-Man Choi; Nai-Chung Fong; Vivian Wing-Yi Li; Tsz-Wai Ho; Eugene Yu-Hin Chan; Alison Lap-Tak Ma; Yiu-Fai Cheung
Journal:  Pediatr Nephrol       Date:  2020-02-03       Impact factor: 3.714

5.  Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload.

Authors:  Elia C El Hajj; Milad C El Hajj; Van K Ninh; Jason D Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

Review 6.  Myocardial tissue characterisation using echocardiographic deformation imaging.

Authors:  Mohammed A Moharram; Regis R Lamberts; Gillian Whalley; Michael J A Williams; Sean Coffey
Journal:  Cardiovasc Ultrasound       Date:  2019-11-15       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.